These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17512422)

  • 1. Key lessons from cases worldwide.
    Wang L
    Am J Cardiol; 2007 May; 99(10A):34G-40G. PubMed ID: 17512422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fundamentals of intrathoracic impedance monitoring in heart failure.
    Wang L
    Am J Cardiol; 2007 May; 99(10A):3G-10G. PubMed ID: 17512421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating device-based monitoring into clinical practice: insights from a large heart failure clinic.
    Small RS
    Am J Cardiol; 2007 May; 99(10A):17G-22G. PubMed ID: 17512418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case studies in advanced monitoring: OptiVol.
    Tang WH
    Rev Cardiovasc Med; 2006; 7 Suppl 1():S62-6. PubMed ID: 17009449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathoracic impedance monitoring to detect chronic heart failure deterioration: relationship to changes in NT-proBNP.
    Lüthje L; Vollmann D; Drescher T; Schott P; Zenker D; Hasenfuss G; Unterberg C
    Eur J Heart Fail; 2007; 9(6-7):716-22. PubMed ID: 17462948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathoracic impedance monitoring to predict decompensated heart failure.
    Ypenburg C; Bax JJ; van der Wall EE; Schalij MJ; van Erven L
    Am J Cardiol; 2007 Feb; 99(4):554-7. PubMed ID: 17293202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial.
    Conraads VM; Tavazzi L; Santini M; Oliva F; Gerritse B; Yu CM; Cowie MR
    Eur Heart J; 2011 Sep; 32(18):2266-73. PubMed ID: 21362703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of device diagnostics in the outpatient management of heart failure.
    Germany R; Murray C
    Am J Cardiol; 2007 May; 99(10A):11G-6G. PubMed ID: 17512417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of device diagnostics as an educational tool to improve patient adherence.
    Rathman L
    Am J Cardiol; 2007 May; 99(10A):29G-33G. PubMed ID: 17512420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistently abnormal device-detected thoracic impedance and OptiVol fluid index related to breast reconstruction surgery.
    Nagra B; Ibrahim T; Shah AN; Kantharia BK
    Pacing Clin Electrophysiol; 2023 Apr; 46(4):323-326. PubMed ID: 36272170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased Intrathoracic Impedance Associated With OptiVol Alert Can Diagnose Increased B-Type Natriuretic Peptide - MOMOTARO (Monitoring and Management of OptiVol Alert to Reduce Heart Failure Hospitalization) Study - .
    Nishii N; Kubo M; Okamoto Y; Fujii S; Watanabe A; Toyama Y; Yamada T; Doi M; Morita H; Ito H;
    Circ J; 2015; 79(6):1315-22. PubMed ID: 25787230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OptiVol fluid status monitoring with an implantable cardiac device: a heart failure management system.
    Yamokoski LM; Haas GJ; Gans B; Abraham WT
    Expert Rev Med Devices; 2007 Nov; 4(6):775-80. PubMed ID: 18035943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of paroxysmal atrial tachyarrhythmias to volume overload: assessment by implanted transpulmonary impedance monitoring.
    Jhanjee R; Templeton GA; Sattiraju S; Nguyen J; Sakaguchi S; Lu F; Ermis C; Milstein S; Van Heel L; Lurie KG; Benditt DG
    Circ Arrhythm Electrophysiol; 2009 Oct; 2(5):488-94. PubMed ID: 19843916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Device monitoring of intrathoracic impedance: clinical observations from a patient registry.
    Andriulli J
    Am J Cardiol; 2007 May; 99(10A):23G-8G. PubMed ID: 17512419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refined heart failure detection algorithm for improved clinical reliability of OptiVol alerts in CRT-D recipients.
    Vamos M; Nyolczas N; Bari Z; Bogyi P; Muk B; Szabo B; Ancsin B; Kiss RG; Duray GZ
    Cardiol J; 2018; 25(2):236-244. PubMed ID: 28653309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized Clinical evaluatiON of wireless fluid monitoriNg and rEmote ICD managemenT using OptiVol alert-based predefined management to reduce cardiac decompensation and health care utilization: the CONNECT-OptiVol study.
    Zabel M; Vollmann D; Lüthje L; Seegers J; Sohns C; Zenker D; Hasenfuss G
    Contemp Clin Trials; 2013 Jan; 34(1):109-16. PubMed ID: 23073567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating monitoring into the infrastructure and workflow of routine practice: OptiVol.
    Small R
    Rev Cardiovasc Med; 2006; 7 Suppl 1():S47-55. PubMed ID: 16955060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OptiVol for Volume Assessment in Patients With Continuous Flow Left Ventricular Assist Device.
    Zeitler EP; Cooper LB; Clare RM; Chiswell K; Lowenstern A; Rogers JG; Milano CA; Schroder JN; Al-Khatib SM; Mentz RJ
    ASAIO J; 2021 Feb; 67(2):192-195. PubMed ID: 33512914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of intrathoracic impedance monitoring in pediatric and congenital heart disease.
    LaPage MJ; von Alvensleben J; Dick M; Serwer G; Bradley DJ
    Pacing Clin Electrophysiol; 2013 Aug; 36(8):994-9. PubMed ID: 23594286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale, design, and baseline characteristics of a Program to Assess and Review Trending INformation and Evaluate CorRelation to Symptoms in Patients with Heart Failure (PARTNERS HF).
    Whellan DJ; O'Connor CM; Ousdigian KT; Lung TH;
    Am Heart J; 2008 Nov; 156(5):833-9, 839.e2. PubMed ID: 19061695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.